A nationwide study from South Korea, which utilized ultrasonography and magnetic resonance elastography to investigate hepatic steatosis and fibrosis, reported MAFLD prevalence of 34% [12]
ESSENCE Phase 3 semaglutide in MASH data supported FDA approval in March 2024 , creating a premium pricing tier in a disease category with USD 17.4 billion addressable market and no prior approved pharmacotherapy
Three regulators, no clear owner When a patient sees a Medvi ad on social media, clicks through, fills out an intake form, is prescribed a compounded GLP-1 by a physician theyve never met and receives medicine from a pharmacy, at least three federal regulatory agencies oversee that interaction, plus the relevant state medical board and possibly the FTCs digital advertising division
Its mechanism involves stimulating natural GH release specifically to reduce visceral adipose tissue, with research originally focused on HIV-associated lipodystrophy